These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29548740)

  • 1. Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia.
    Garg P; Jaryal AK; Kachhawa G; Deepak KK; Kriplani A
    Pregnancy Hypertens; 2018 Oct; 14():245-251. PubMed ID: 29548740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
    Bian Z; Shixia C; Duan T
    PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.
    Dröge LA; Höller A; Ehrlich L; Verlohren S; Henrich W; Perschel FH
    Pregnancy Hypertens; 2017 Apr; 8():31-36. PubMed ID: 28501276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
    Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
    Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of copeptin, placental growth factor and total annexin V microparticles for prediction of preeclampsia at 10-14 weeks of gestation.
    Jadli A; Ghosh K; Satoskar P; Damania K; Bansal V; Shetty S
    Placenta; 2017 Oct; 58():67-73. PubMed ID: 28962698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of preeclampsia using combination of biomarkers at 18-23 weeks of gestation: A nested case-control study.
    Jadli A; Ghosh K; Damania K; Satoskar P; Bansal V; Shetty S
    Pregnancy Hypertens; 2019 Jul; 17():20-27. PubMed ID: 31487641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential profile of endothelial functions and arterial stiffness in preeclampsia during the course of pregnancy.
    Garg P; Jaryal AK; Kachhawa G; Kriplani A; Deepak KK
    Pregnancy Hypertens; 2019 Oct; 18():88-95. PubMed ID: 31585347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.
    Rohra DK; Zeb A; Qureishi RN; Azam SI; Khan NB; Zuberi HS; Sikandar R
    Natl Med J India; 2012; 25(2):68-73. PubMed ID: 22686711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.
    Tsiakkas A; Cazacu R; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Apr; 47(4):472-7. PubMed ID: 26582455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Bioavailability of Nitric Oxide and L-Arginine Is a Key Determinant of Endothelial Dysfunction in Preeclampsia.
    Tashie W; Fondjo LA; Owiredu WKBA; Ephraim RKD; Asare L; Adu-Gyamfi EA; Seidu L
    Biomed Res Int; 2020; 2020():3251956. PubMed ID: 33145345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
    Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.
    Manriquez Rocha B; Mbofana F; Loquiha O; Mudenyanga C; Ukah UV; Magee LA; von Dadelszen P
    Pregnancy Hypertens; 2018 Jan; 11():26-31. PubMed ID: 29523269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.